Peter Söhlemann

Title: The Innovations of Peter Söhlemann

Introduction

Peter Söhlemann is a notable inventor based in Neubiberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the processing of recombinant human G-CSF precursor. His work has implications for medical advancements and therapeutic applications.

Latest Patents

Peter Söhlemann holds a patent for the "Processing of recombinant human G-CSF precursor." This patent involves a G-CSF precursor that comprises a signal peptide and a G-CSF peptide. The signal peptide has the sequence of the human wild-type signal peptide of the human G-CSF/b molecule, with at least one of the specified mutations. This innovation is crucial for enhancing the efficacy of treatments involving G-CSF.

Career Highlights

Söhlemann is currently associated with Octapharma AG, a company known for its focus on human protein therapies. His role at Octapharma AG allows him to leverage his expertise in biotechnology and contribute to the development of innovative medical solutions.

Collaborations

Peter has collaborated with notable colleagues, including Carola Schröder and Elisabeth Casademunt. These collaborations have fostered a productive environment for research and development in their respective fields.

Conclusion

Peter Söhlemann's contributions to biotechnology, particularly through his patent on G-CSF precursor processing, highlight his role as an influential inventor. His work continues to impact the medical field positively.